Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/07/026671
CTRI/2020/07/026671
Not yet recruiting
未知

A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment

Bisleri charitable trust0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor
Bisleri charitable trust
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Bisleri charitable trust

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients confirmed to be COVID\-19 positive by quantitative real time polymerase chain reaction (QRT\-PCR) assay
  • •2\. Patients that meet any one of the criteria of moderate stage
  • •3\. Patients who give written informed consent.
  • •4\. Age 18 â?? 65 years

Exclusion Criteria

  • •1\. Mild or severe stage
  • •2\. G6PD deficiency
  • •3\. Hyperthyroidism
  • •4\. Bleeding disorders (any coagulopathies)
  • •5\. Chronic uncontrolled illnesses such as uncontrolled diabetes, uncontrolled hypertension chronic renal failure, chronic liver disease, chronic neurodegenerative disorders, chronic heart conditions (chronic heart failure, chronic angina, previous
  • •myocardial infarction), malignancies, etc.,
  • •6\. Pregnant and lactating women
  • •7\. Patients on immunosuppressant drugs
  • •8\. Patients with a history of organ transplantation
  • •9\. Patients who are participating in other clinical trials

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A medical records based study for Tou-Jie-Qu-Wen Granules in the Treatment of mild and moderate patients with novel coronavirus pneumonia (COVID-19)COVID-19
ITMCTR2000003144Guangzhou Eighth People's Hospital
Active, not recruiting
Not Applicable
HS COVID-related post-traumatic stress disorder (PTSD) experimental treatment trialPost-Traumatic Stress Disorder (PTSD)Mental and Behavioural Disorders
ISRCTN52834682King's College London18
Active, not recruiting
Phase 1
Treatments of COVID-19 in primary care in the NetherlandsPatients with symptomatic COVID-19 in the community and in primary care, who are at higher risk of a complicated illness course.MedDRA version: 23.0Level: PTClassification code: 10084268Term: COVID-19 Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]
CTIS2022-501559-99-00Maastricht University682
Not yet recruiting
Not Applicable
Precalence study on ICU Treatment of COVID-19 patients in Northern and Western Saxony in the first half of 2020 - PraeCoSaJ12.8J80.09Other viral pneumonia
DRKS00021705Klinik für Anästhesiologie und IntensivtherapieUniversitätsklinikum Leipzig100
Recruiting
Not Applicable
Prospective observational study of COVID-19 patients in the TOKUSHUKAI GROUPThe purpose of this study is to collect information of the clinical course of patients with COVID-19 treated at Tokushukai hospitals with and without antiviral drugs and to explore the clinical course in the acute phase, the frequency of severe disease, and frequency of post COVID-19 condition by the treatment, after adjusting by patient background including risk factor(s) and symptoms at the time of registration.
JPRN-UMIN000053506Shionogi & Co., Ltd.30,000